Two products can sit on the same shelf, carry the same word on the label, and act very differently in the body. That is the core of the 7-OH vs. kratom debate.
Traditional kratom comes from a plant. Concentrated 7-OH products are formulated or processed to deliver much higher levels of a single compound. They are not the same substance. If you or someone you love uses either one, knowing the difference matters.
This guide compares traditional kratom and concentrated 7-OH, explains FDA safety concerns, dependence and withdrawal risks, current New Jersey regulations, warning signs, and treatment options for New Jersey readers.
7-hydroxymitragynine vs Whole-Leaf Kratom
Kratom comes from Mitragyna speciosa, a tropical tree native to Southeast Asia. Traditionally, people have used its natural leaves by crushing them or brewing them in water.
7-hydroxymitragynine is just one of the compounds found in kratom. Whole-leaf kratom contains many natural compounds, while a concentrated product contains mainly one.
7-OH Is an Alkaloid Found Naturally in Kratom
7-hydroxymitragynine, or 7-OH, is an alkaloid that occurs naturally in kratom leaves. The FDA classifies it as a minor component of the plant, making up less than 2% of the plant’s total alkaloid content.
Your body also makes 7-OH. After you use kratom, your body converts some mitragynine into 7-OH. This means 7-OH is just one compound in kratom, not the whole plant.
Concentrated 7-OH Products Change the Exposure
Some products chemically convert mitragynine into 7-OH, while others are formulated to contain high concentrations of 7-OH.
Unlike raw kratom leaf, these products contain higher concentrations of 7-OH and may come as tablets, gummies, or shots. This can make the dose hard to judge.
The Label “Kratom” Does Not Tell the Whole Story
Kratom products range from kratom powder and capsules to tea, extract shots, and gummies. Some sold in smoke shops are marketed as kratom but are enriched with 7-OH.
Kratom vs 7-OH labels can blur, and product quality varies from brand to brand.
7-OH vs Natural Kratom at a Glance
The main difference between whole-leaf kratom and concentrated 7-OH products is their alkaloid composition. The comparison below describes broad product categories; individual formulations can differ, so a label alone cannot establish a product’s actual composition or risk.
| Factor | Natural/Whole-Leaf Kratom | Concentrated 7-OH Products |
|---|---|---|
| Source | Kratom leaf | Products containing concentrated or enhanced 7-OH |
| Main alkaloids | Many, mostly mitragynine | Mainly 7-OH |
| Natural 7-OH presence | Trace amounts | Deliberately concentrated |
| Product forms | Leaf, powder, capsules, tea, extracts | Tablets, gummies, shots, extracts |
| Pharmacologic concern | Complex, still not fully understood | Strong opioid-like activity |
| Dependence potential | Possible | Significant concern |
| Regulatory status | Varies by state | Changing fast; verify current status |
| Treatment relevance | Can involve dependence and withdrawal | Same, with extra caution |
Potency, Composition, and Opioid-Like Effects
Laboratory research indicates that 7-hydroxymitragynine has opioid-receptor activity and differs pharmacologically from mitragynine. However, laboratory potency comparisons should not be treated as direct predictions of the effects of every commercial product. Formulation, composition, amount consumed, other substances, and individual circumstances all matter.
Natural Kratom Contains Multiple Alkaloids
The FDA says kratom contains more than 50 alkaloids. Most research focuses on mitragynine and 7-hydroxymitragynine, its best-studied active compounds.
Raw kratom leaf is chemically complex. The agency also notes that no well-designed study has examined its abuse potential in humans to date.
7-OH Has Greater Opioid-Receptor Activity
Laboratory studies show that 7-OH has substantially greater opioid-receptor potency than mitragynine. However, laboratory findings do not directly predict the effects of every commercial product. Actual risks depend on product composition, concentration, amount consumed, other substances, and individual factors.
The FDA reports substantially greater potency than mitragynine and even morphine. Depending on the lab test, FDA-reviewed studies put 7-OH at roughly 5 to 50 times more potent than mitragynine. Overall, 7-OH behaves more like a classic opioid than a leaf.
The FDA calls concentrated 7-OH an emerging public health threat. High exposure can cause sedation and respiratory depression, meaning slowed breathing.
Learn more: What Happens During a Kratom Overdose? Warning Signs and Emergency Steps.
Concentration Is a Critical Part of the Risk Conversation
Kratom and 7-hydroxymitragynine are not interchangeable, and treating kratom or 7-OH that way misleads people.
A cup of tea from raw kratom leaf and a high-potency 7-OH tablet are not equal. A safe dose has not been established for these products.
Dependence and Withdrawal Can Develop With Both
Whether someone uses 7-OH or kratom, kratom addiction and 7-OH addiction can look alike at first. Watch for these signs of developing dependence:
- Needing more to get the same effect
- Trouble cutting back
- Constant cravings
- Planning your day around use
- Using despite harm to work, health, or relationships
- Withdrawal symptoms after stopping
For a closer look, read Signs of a 7-OH Addiction You Should Know Before It Gets Worse.
Withdrawal Can Become a Barrier to Stopping
Kratom withdrawal often feels like opioid withdrawal. Reported symptoms include:
- Restlessness
- Body aches
- Fatigue
- Irritability
- Cold sweats
- Anxiety
- Stomach upset
- Poor sleep
Learn more: 7-OH Withdrawal Symptoms: Signs, Timeline, and Treatment Options.
7-OH Dependence Deserves Particular Attention
In August 2026, the American College of Medical Toxicology (ACMT) stated that clinical experience links 7-OH to opioid-like effects, including dependence and withdrawal.
It also noted that doctors have treated these cases with medications for opioid use disorder, such as buprenorphine or methadone.
According to a CDC report, poison centers logged 14,449 kratom-related reports from 2015 to 2025. Annual cases rose from 258 in 2015 to 3,434 in 2025.
Poison centers also recorded 233 kratom-related deaths in that period. In 79% of them, more than one substance was involved.
The data cannot separate leaf from 7-OH. Still, the pattern shows why addiction and overdose risks need attention.
The “Natural” Label Does Not Eliminate Addiction Risk
Plant-based does not mean low risk. Botanical origin does not rule out dependence, and kratom users can develop a substance use disorder.
Health risks rise with misuse, and the risks of addiction apply to leaf products too. Marketing words can hide what is inside, so addiction risks are easy to underestimate. The same CDC report noted sharp increases among adults 40 to 59.
New Jersey’s 7-OH Landscape Is Changing
Last reviewed: October 12, 2026. Laws and regulations in this section change quickly.
Federal officials have announced further scheduling actions for 7-OH, while New Jersey lawmakers have considered additional restrictions. Here’s the regulatory status as of October 12, 2026.
Federal Regulatory Attention Has Increased
On July 1, 2026, the DEA announced its intent to place certain 7-OH products in Schedule I temporarily, and published a notice in the Federal Register on July 6.
On October 9, 2026, the Department of Justice announced that the DEA would issue a new Notice of Intent based on updated scientific recommendations from the Department of Health and Human Services (HHS). The updated approach proposes thresholds based on 7-OH concentration and its ratio to mitragynine to help distinguish concentrated products from botanical kratom.
As of October 12, 2026, the DOJ announcement stated that the DEA had not yet issued a temporary scheduling order for 7-OH. The related compounds MGPI, MGM-15, and MGM-16 were temporarily placed in Schedule I on August 26, 2026.
Because federal scheduling actions can change, check the latest DOJ announcements before publishing or updating this section.
New Jersey Has Considered Additional 7-OH Restrictions
Senate Bill 301 would make 7-OH a Schedule I controlled substance in New Jersey.
On March 16, 2026, the Senate Health, Human Services and Senior Citizens Committee approved advancing the bill and passed it along to the Senate Budget and Appropriations Committee for further evaluation. As of October 12, 2026, it had not become law.
Other bills in the Legislature would either regulate kratom sales or criminalize kratom. None of them is law.
Read more: Why Is 7-OH Being Banned in New Jersey? What’s Changing and Why
Verify Current Rules Before Buying or Possessing These Products
Laws and regulations may change quickly. Check official New Jersey and federal sources before you buy or possess anything.
Signs It May Be Time to Seek Professional Help
Consider an assessment if you notice:
- Missed work or school
- Strained relationships or money trouble
- Using to feel normal
- Mixing kratom or 7-OH with alcohol, benzodiazepines, or other drugs
- Fear of quitting alone
Families worried about a loved one may also consider an intervention.
Please get medical guidance if withdrawal feels severe, since stopping without medical supervision can be risky.
If you are in crisis, call or text 988. Call 911 right away for trouble breathing, seizures, or unresponsiveness. Naloxone can reverse an opioid overdose, so keep it on hand and learn how to use it.
Treatment Options for Kratom and 7-OH Dependence in New Jersey
Addiction treatment starts with an assessment. Not everyone needs the same level of care, so treatment programs span inpatient and outpatient settings.
Options may include:
- Medically supervised detox
- Inpatient treatment
- Partial care
- Intensive outpatient
- Outpatient treatment
Teams may use medication-assisted treatment when it fits, along with care for mental health disorders and aftercare planning.
Evidence-based treatment and opioid withdrawal protocols guide this work.
Professional treatment should match the person, not the product, whether the concern is 7-OH and kratom together or one alone.
Concerned About Kratom or 7-OH Dependence? Talk With Relevance Recovery
Call (866) 698-4268 to start a confidential assessment and talk through your options.
Visit the Relevance Recovery admissions page to see how intake, clinical assessment, and insurance checks work.
Frequently Asked Questions
Is 7-OH found naturally in kratom?
Yes. 7-hydroxymitragynine (7-OH) occurs naturally in kratom in small amounts, but concentrated products may contain much higher levels.
Can 7-OH cause withdrawal?
Yes. Regular use of 7-OH products can lead to dependence and withdrawal symptoms, which may require professional support.
Can natural kratom cause dependence?
Yes. Frequent kratom use can cause physical dependence, cravings, and withdrawal symptoms when someone reduces or stops using it.
Is kratom regulated in New Jersey?
New Jersey has not banned natural kratom outright, but MGPI, MGM-15, and MGM-16 are controlled substances under a temporary scheduling order that remains in effect until at least August 26, 2028, unless changed by the Division.
Is it safe to quit kratom or 7-OH cold turkey?
Not always. Withdrawal can be difficult, so talk with a clinician first. A clinician may prescribe a medication such as buprenorphine as part of a treatment plan.
